Cargando…

Elevated fibrous sheath interacting protein 1 levels are associated with poor prognosis in non-small cell lung cancer patients

In this study, we examined the expression and prognostic value of fibrous sheath interacting protein 1 (FSIP1) in 202 non-small cell lung cancer (NSCLC) patients who underwent lung cancer resection at Shengjing Hospital of China Medical University. FSIP1 mRNA and protein expression were measured in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Yuqiang, Xu, Ran, Liu, Xiaoying, Shi, Wenjun, Han, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355335/ https://www.ncbi.nlm.nih.gov/pubmed/28086239 http://dx.doi.org/10.18632/oncotarget.14575

Ejemplares similares

Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target
por: Sun, Ming, et al.
Publicado: (2017)

Clinical significance of expression of fibrous sheath interacting protein 1 in colon cancer
por: Wu, Hui-Ying, et al.
Publicado: (2020)

Sperm protein 17 is expressed in the sperm fibrous sheath
por: Chiriva-Internati, Maurizio, et al.
Publicado: (2009)

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021)

CDK14 expression is elevated in patients with non-small cell lung cancer and correlated with poor prognosis
por: Yang, Yong, et al.
Publicado: (2021)

The long noncoding RNA ANRIL acts as an oncogene and contributes to paclitaxel resistance of lung adenocarcinoma A549 cells
por: Xu, Ran, et al.
Publicado: (2017)

Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
por: Sun, Yifan, et al.
Publicado: (2017)

Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer
por: Zang, Jialan, et al.
Publicado: (2017)

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
por: Cho, W C S, et al.
Publicado: (2010)

Elevated serum soluble programmed cell death ligand 1 concentration as a potential marker for poor prognosis in small cell lung cancer patients with chemotherapy
por: Jin, Jianjun, et al.
Publicado: (2018)

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
por: HONG, LING-ZHI, et al.
Publicado: (2013)

Elevated expression of lung development-related protein HSP90β indicates poor prognosis in non-small cell lung cancer through affecting the cell cycle and apoptosis
por: Wang, Xiang, et al.
Publicado: (2021)

Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC)
por: Tang, Zhiyuan, et al.
Publicado: (2016)

Fibrous flexor sheath ganglion and trigger thumb in a 14-year-old female
por: Suresh, S. S., et al.
Publicado: (2009)

Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer
por: Xu, Tao, et al.
Publicado: (2020)

Elevated plasma YKL-40 level is found in the dogs with cancer and is related to poor prognosis
por: Cheng, Kai-Chung, et al.
Publicado: (2019)

Elevated plasma D-dimer levels are associated with the poor prognosis of critically ill children
por: Wang, Guan, et al.
Publicado: (2022)

Elevated air quality index and fine particulate matter levels contribute to the poor prognosis and progression of nonsmall‐cell lung cancer: A cohort study combined with external validation
por: Li, Jing, et al.
Publicado: (2022)

Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer
por: Wen, Qiuyuan, et al.
Publicado: (2019)

Elevated pretreatment platelet distribution width and platelet count predict poor prognosis in nasopharyngeal carcinoma
por: Xie, XueCheng, et al.
Publicado: (2017)

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer()
por: Zhu, Jinhong, et al.
Publicado: (2016)

The Small Fibrous Prostate
por: Fowler, A. L.
Publicado: (1915)

Elevated Levels of Dickkopf-1 Are Associated with β-Catenin Accumulation and Poor Prognosis in Patients with Chondrosarcoma
por: Chen, Changbao, et al.
Publicado: (2014)

Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer
por: Xu, Tao, et al.
Publicado: (2020)

Elevated Serum Chloride Levels Contribute to a Poor Prognosis in Patients with IgA Nephropathy
por: Zhai, Yaling, et al.
Publicado: (2021)

Does pretreatment elevated calcitonin level cause the poor prognosis in patients with medullary thyroid cancer?
por: Zhang, Han, et al.
Publicado: (2022)

Overexpression of Muscarinic Receptor 3 Promotes Metastasis and Predicts Poor Prognosis in Non–Small-Cell Lung Cancer
por: Lin, Gengpeng, et al.
Publicado: (2014)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

The expression of aplysia ras homolog I (ARHI) and its inhibitory effect on cell biological behavior in esophageal squamous cell carcinoma
por: Mao, Yuqiang, et al.
Publicado: (2017)

Solitary fibrous tumor of the pleura: a rare cause of elevation of the right lung base
por: Souza, Arthur Soares, et al.
Publicado: (2019)

Cell cycle‐related and expression‐elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non‐small‐cell lung cancer
por: Li, Weimiao, et al.
Publicado: (2018)

High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis
por: Kou, Wenxin, et al.
Publicado: (2022)

High DSCC1 Level Predicts Poor Prognosis of Lung Adenocarcinoma
por: Chang, Sisi, et al.
Publicado: (2021)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

Enhanced expression of cohesin loading factor NIPBL confers poor prognosis and chemotherapy resistance in non-small cell lung cancer
por: Xu, Weizhen, et al.
Publicado: (2015)

Elevated CELSR3 expression is associated with hepatocarcinogenesis and poor prognosis
por: Ouyang, Xiwu, et al.
Publicado: (2020)

Elevated RGMA Expression Predicts Poor Prognosis in Patients with Glioblastoma
por: Phan, Thi Le, et al.
Publicado: (2021)

Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer
por: Sun, Lichao, et al.
Publicado: (2019)

Flot-2 Expression Correlates with EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer
por: Wen, Qiuyuan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t08gk0ibb2eefkul0tn4kah3jm